Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on THI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Patent CN116041354A reveals a mild palladium-catalyzed [5+3] cycloaddition for high-purity heterocyclic intermediates, offering significant cost reduction in API manufacturing.
Patent CN116041354A details a novel Pd-catalyzed [5+3] reaction for heterocycles, offering cost reduction and high enantioselectivity for pharma supply chains.
Patent CN110878068A details a novel fluorescent rosin derivative with anticancer activity, offering a cost-effective route for pharmaceutical intermediate manufacturing.
Patent CN115928111A reveals a metal-free electrochemical route for 7-thiocyano-3,4-dihydroquinoxalin-2(1H)-ones, offering cost reduction and high purity for pharmaceutical intermediates.
Novel silica-supported catalytic route for benzothiazole derivatives ensures high purity and simplified post-treatment for reliable pharmaceutical intermediate supply chains.
Patent CN119654332A reveals a stereoselective route for DNMT1 inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111423457A reveals a mild, metal-free synthesis of 1,9a-dihydropyrido[2,1-c][1,4]thiazine compounds offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN116178470B reveals a safer one-pot synthesis for ethinylestradiol eliminating acetylene gas. Enhances supply chain reliability and reduces manufacturing complexity.
Patent CN105263913B details a safer thio-1,2,4-triazole synthesis route offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN114716356A details a green Rh-catalyzed route for isothiocyanates, offering safer alternatives to thiophosgene and improved supply chain reliability for fine chemical manufacturing.
Patent CN1013113B details a novel route for N-(thiophen-3-yl)-chloroacetamide precursors. This method offers cost reduction in herbicide manufacturing via efficient cyclization.
Patent CN112125879A discloses a nickel-catalyzed Kumada coupling route for Canagliflozin intermediate. High yield, mild conditions, scalable industrial process reducing cost.
Novel oxidative coupling route for NSC128981 reduces toxic reagents. Enhances supply chain reliability for pharmaceutical intermediates manufacturing with high purity standards.
Patent CN112194620B reveals a high-purity route for ethionamide intermediates, eliminating isomers and ensuring cost reduction in API manufacturing.
Patent CN110372718B discloses a novel one-pot synthesis for difluoromethylthiochromonothiophene compounds. This method offers cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN111995620A reveals a KHSO4-catalyzed route for 1,3,4-thiadiazoles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110724115B reveals a green synthesis route for thiadiazoles using choline chloride-urea DES, offering high purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN108358868A details a novel radical method for high-purity benzothiazoles, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel patent CN115925598B enables safe thiofluoroformamide production without toxic gases offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.